Jaclyn Phillips

Coordinating counsel for the National Association of REALTORS®.

Representing Hikma Pharmaceuticals against so-called "reverse payment" allegations relating to Jazz Pharmaceuticals' landmark drug pending in N.D. Cal. and California state court.

Counsel for amici curiae International Center for Law and Economics and scholars of law and economics supporting Defendant-Appellee Facebook, Inc. (now, Meta) in State of New York v. Facebook, Inc., No. 21-7078 (D.C. Cir. Mar. 28, 2022). 

Represented Gilead in complex antitrust class actions pending in N.D. Cal. concerning numerous innovative HIV treatments and related joint venture agreements and patent settlements. 

Represented Pfizer in ground-breaking litigation challenging Johnson & Johnson's efforts to deter biosimilar competition in respect of its blockbuster biologic, Remicade.

Representation of an airline in a class action alleging violations of Section 1 of the Sherman Act and state law, resulting in a successful motion to dismiss in the District of Maryland.

Representation of Allergan/Warner Chilcott in a reversal of class certification by the First Circuit US Court of Appeals. The ruling bans the widespread use of aggregate proof and post-trial affidavits as a substitute for fact-finding by juries under the Seventh Amendment of the US Constitution and Rule 23.

Representation of Boehringer Ingelheim in an antitrust class action challenging a patent settlement.

Representation of Allergan/Warner Chilcott in a number of antitrust class actions involving challenges to new-product introductions, patent settlements, and license agreements.

Key member of trial team that represented Anthem, Inc. against claims brought by the US Department of Justice to block Anthem's US$54 billion acquisition of Cigna Corporation.

Following trial, an expedited appeal to the D.C. Circuit was filed. The D.C. Circuit granted expedition, reviewed the appeal, heard oral argument and ruled on the merits, all within the span of two and a half months. This was the first time the D.C. Circuit has ever granted and heard an expedited appeal of a merger matter in such a compressed time frame, paving the way for more merger review in this appellate court. After receiving a split in the D.C. Circuit and a highly favorable dissent, Anthem filed a petition for a writ of certiorari to the Supreme Court only one week later.

Key member of a number of appellate teams that represented clients in the First, Second, Third, and D.C. Circuits.